QLGN

Qualigen Therapeutics (QLGN)

Qualigen Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:QLGN

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/27	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/12/20	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/12/11	04:27	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/12/05	23:00	GlobeNewswire Inc.	Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/26	07:00	GlobeNewswire Inc.	Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/23	07:28	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/22	07:10	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/22	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/19	23:00	GlobeNewswire Inc.	Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/16	06:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/15	06:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/14	07:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/09	07:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/02	05:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/01	22:00	GlobeNewswire Inc.	Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/30	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/25	06:06	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/23	05:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/18	05:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/10	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/10	05:10	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/27	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/27	06:10	GlobeNewswire Inc.	Qualigen Therapeutics, Inc. Announces management changes.	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/21	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/20	22:00	GlobeNewswire Inc.	Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/10	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/07	06:00	GlobeNewswire Inc.	Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/07	05:30	GlobeNewswire Inc.	Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/07	04:46	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/05	22:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc